FIELD: organic chemistry, ergot alkaloids. SUBSTANCE: invention relates to derivatives of ergoline of the general formula (I) where R1 is C1-4-alkyl; A - OH, or a residue of the formula (a) , (b) , (c) ; R2 - hydrogen, bromine atom, -S-C1-4-alkyl; - C1-5-alkyl or hydrogen atom; n = 0, 1 or 2; m = 1 or 2; R4 - hydrogen atom, C1-7-alkyl, C3-7-cycloalkyl, adamantyl, C1-5-alkylphenyl, C2-alkenylphenyl, phenyl substituted with CF3 or one or two alkoxy-groups, naphthyl, benzothiophene, alkenylfuryl, 5-6-membered heterocyclic ring containing 1-2 heteroatoms taken from N, S and possibly substituted with alkyl, phenyl or halogen atom; X is O or S; or their pharmaceutically acceptable salts that can be used for state control caused by serotonine-ergic disorders. EFFECT: improved method of synthesis. 5 cl, 2 tbl, 48 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PRODUCTION OF DERIVATIVE OF ERGOLINE | 1993 |
|
RU2118323C1 |
FLUORINATED DERIVATIVES OF 17β-SUBSTITUTED-4-AZA--5α-ANDROSTANE- -3-ONE, PHARMACEUTICAL COMPOSITION | 1993 |
|
RU2125061C1 |
AZAANTRACYCLINE DERIVATIVES AND PHARMACEUTICAL COMPOSITION | 1996 |
|
RU2159245C2 |
ANTHRACYCLINE GLYCOSIDE, METHOD OF ITS SYNTHESIS, PHARMACEUTICAL COMPOSITION | 1992 |
|
RU2118328C1 |
DERIVATIVES OF ANTHRACYCLINONE AND THEIR USE IN AMYLOIDOSIS | 1995 |
|
RU2167661C2 |
BIOLOGICALLY-ACTIVE POLYMER-BOUND ANTHRACYCLINES, INTERMEDIATES, PREPARATION METHODS, AND PHARMACEUTICAL COMPOSITION | 1994 |
|
RU2145965C1 |
DERIVATIVES OF 3'-AZIRIDINO-ANTHRACYCLINE, METHODS OF SYNTHESIS, PHARMACEUTICAL COMPOSITION | 1994 |
|
RU2149163C1 |
ANTHRACYCLIN DERIVATIVES | 1995 |
|
RU2159619C2 |
POLYMERIC CONJUGATE, PHARMACEUTICAL COMPOSITION | 1994 |
|
RU2149646C1 |
BINDING AGENT FOR BIOACTIVE PREPARATIONS, METHOD OF ITS SYNTHESIS AND PHARMACEUTICAL COMPOSITIONS | 1991 |
|
RU2116087C1 |
Authors
Dates
1999-06-10—Published
1993-11-26—Filed